Squarepoint Ops LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 201 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,977,499
-25.0%
77,945
-29.2%
0.01%
-41.7%
Q2 2023$3,972,173
+1329.5%
110,124
+1413.5%
0.01%
+1100.0%
Q1 2023$277,870
-97.0%
7,276
-95.5%
0.00%
-97.2%
Q4 2022$9,232,253
+3762.9%
162,254
+2581.9%
0.04%
+3500.0%
Q3 2022$239,000
-96.0%
6,050
-95.5%
0.00%
-97.0%
Q2 2022$5,973,000
+541.6%
135,753
+481.6%
0.03%
+725.0%
Q1 2022$931,000
-72.6%
23,341
-72.4%
0.00%
-55.6%
Q4 2021$3,399,000
+82.6%
84,531
+84.8%
0.01%
+80.0%
Q3 2021$1,861,000
+211.2%
45,742
+218.9%
0.01%
+25.0%
Q1 2021$598,000
-9.0%
14,345
-6.8%
0.00%
-20.0%
Q4 2020$657,000
-64.3%
15,391
-77.6%
0.01%
-83.3%
Q2 2020$1,840,000
+12.0%
68,646
-25.9%
0.03%
+200.0%
Q4 2019$1,643,000
+495.3%
92,668
+420.7%
0.01%
+400.0%
Q3 2019$276,000
-58.3%
17,798
-53.8%
0.00%
-66.7%
Q2 2019$662,000
-76.1%
38,513
-77.6%
0.01%
-79.3%
Q1 2019$2,769,000
+119.2%
171,972
+99.3%
0.03%
+93.3%
Q4 2018$1,263,000
-42.7%
86,298
-28.9%
0.02%
-42.3%
Q3 2018$2,206,000
+127.4%
121,392
+111.1%
0.03%
+100.0%
Q2 2018$970,000
+117.0%
57,500
+151.9%
0.01%
+85.7%
Q1 2018$447,000
-66.9%
22,824
-65.7%
0.01%
-70.8%
Q4 2017$1,350,000
+433.6%
66,621
+237.1%
0.02%
+380.0%
Q2 2017$253,000
+68.7%
19,763
+59.4%
0.01%
-50.0%
Q3 2016$150,000
-75.3%
12,400
-64.7%
0.01%
-85.1%
Q4 2015$608,000
+378.7%
35,100
+166.3%
0.07%
-45.5%
Q4 2014$127,00013,1800.12%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$47,091,0006.38%
First Light Asset Management, LLC 2,011,350$83,853,0005.56%
TRAN CAPITAL MANAGEMENT, L.P. 1,353,208$56,415,0005.03%
SNYDER CAPITAL MANAGEMENT L P 2,920,860$121,771,0003.50%
DOHENY ASSET MANAGEMENT /CA 120,028$5,004,0003.39%
SILVERARC CAPITAL MANAGEMENT, LLC 104,945$4,375,0002.39%
Redwood Investments, LLC 542,764$22,628,0001.99%
Kent Lake Capital LLC 85,000$3,544,0001.44%
Lisanti Capital Growth, LLC 263,460$10,984,0001.41%
Bellevue Group AG 3,011,966$125,569,0001.33%
View complete list of HALOZYME THERAPEUTICS INC shareholders